Author Katarzyna Pawlak-Buś
ORIGINAL PAPER
Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study
Reumatologia 2022;60(2):92-100
REVIEW PAPER
2022 Systemic lupus erythematosus remission in clinical practice. Message for Polish rheumatologists
Reumatologia 2022;60(2):125-132
REVIEW PAPER
Kikuchi-Fujimoto disease associated with primary Sjögren’s syndrome – literature review based on a case report
Reumatologia 2020;58(4):251-256
ORIGINAL PAPER
Work instability and associated factors among patients with rheumatoid arthritis in Greater Poland
Reumatologia 2020;58(4):208-212
CASE REPORT
Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up
Katarzyna Pawlak-Buś, Wiktor Schmidt, Michał Olejarz, Anna Czyż, Mieczysław Komarnicki, Piotr Leszczyński
Reumatologia 2019;57(1):50-54
ORIGINAL PAPER
Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study
Anna Kotulska, Eugeniusz J. Kucharz, Piotr Wiland, Marzena Olesińska, Anna Felis-Giemza, Magdalena Kopeć-Mędrek, Aleksandra Zoń-Giebel, Wojciech Romanowski, Lucyna Szymczak-Bartz, Małgorzata Tłustochowicz, Jolanta Lewandowicz, Joanna Kowalska-Majka, Jolanta Bucka, Maria Majdan, Zofia Kiełbik, Mariusz Korkosz, Aneta Bielińska, Piotr Leszczyński, Katarzyna Pawlak-Buś, Mariusz J. Puszczewicz, Dominik Majewski, Katarzyna Smolik, Teresa Migas-Kukla, Małgorzata Sochocka-Bykowska, Maria Szarecka, Bernadeta Luberda, Małgorzata Falenta-Hitnarowicz, Jadwiga Świkszcz-Gniadek, Wanda Lepiarz-Rusek, Grzegorz Rozwadowski, Barbara Chara, Jerzy Zajdel, Zbigniew Zdrojewski, Maria Maciejowska-Roge, Irena Rosmus-Kuczia
Reumatologia 2018;56(3):140-148
ORIGINAL PAPER
Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation
Zofia Guła, Tacjana Barczyńska, Marek Brzosko, Jerzy Gąsowski, Sławomir Jeka, Katarzyna Jodłowska-Cicio, Beata Kwaśny-Krochin, Piotr Leszczyński, Łukasz Lubiński, Katarzyna Łosińska, Katarzyna Pawlak-Buś, Hanna Przepiera-Będzak, Włodzimierz Samborski, Małgorzata Schlabs, Maciej Siedlar, Dorota Sikorska, Jerzy Świerkot, Małgorzata Węgierska, Piotr Wiland, Mariusz Korkosz
Reumatologia 2017;55(2):59-64
CASE REPORT
Zoledronic acid in the treatment of secondary osteoporosis due to homocystinuria
Reumatologia 2010;48(2):133-138
REVIEW PAPER
Sclerostin – new target for bone anabolic therapy in low bone mass
Reumatologia 2010;48(3):183-187
CASE REPORT
Dercum disease: a very rare clinical case in the differentiation process of rheumatic diseases
Reumatologia 2011;49(3):203-207
REVIEW PAPER
Evaluation of quality of life in patients with rheumatoid arthritis treated with leflunomide – a literature review
Reumatologia 2012;50(3):227-232
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
